Killer immunoglobulin-like receptor and human leukocyte antigen-C genotypes in rheumatoid arthritis primary responders and non-responders to anti-TNF-α therapy

The identification of patients who will respond to anti-tumor necrosis factor alpha (anti-TNF-α) therapy will improve the efficacy, safety, and economic impact of these agents. We investigated whether killer cell immunoglobulin-like receptor (KIR) genes are related to response to anti-TNF-α therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: McGeough, Cathy M., Berrar, Daniel, Wright, Gary, Mathews, Clare, Gilmore, Paula, Cunningham, Rodat T., Bjourson, Anthony J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364412/
https://www.ncbi.nlm.nih.gov/pubmed/21373785
http://dx.doi.org/10.1007/s00296-011-1838-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364412/
https://www.ncbi.nlm.nih.gov/pubmed/21373785
http://dx.doi.org/10.1007/s00296-011-1838-6

Ejemplares similares